Anish Patel - 12 Feb 2026 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Patel Anish	CHIEF OPERATING OFFICER	C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER	/s/ Ben Hohl, by power of attorney	17 Feb 2026	0001967163

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELVN	Common Stock	Award	$0	+20,000		$0.000000	20,000	12 Feb 2026	Direct	F1
holding	ELVN	Common Stock						215,011	12 Feb 2026	See footnote	F2

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELVN	Stock Option (right to buy)	Award	$0	+120,000		$0.000000	120,000	12 Feb 2026	Common Stock	120,000	$27.16	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Anish Patel is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Id	Content
F1	These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2	The shares are held by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee.
F3	1/4th of the shares subject to the option will vest on February 12, 2027 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

The Reporting Person is no longer deemed an executive officer under Section 16 after February 12, 2026.